THOMAS WENTE: Open Payments
NPI 1538134002 · SOUTH SIOUX CITY, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,441 in 98 payments from 19 companies in 2025. Trend: 2023 $1,028 · 2024 $1,320 · 2025 $1,441
Food & beverage: $1,390Education: $51
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $257 |
| AstraZeneca Pharmaceuticals LP | 13 | $255 |
| PFIZER INC. | 14 | $204 |
| GlaxoSmithKline, LLC. | 21 | $179 |
| Novo Nordisk Inc | 8 | $144 |
| Astellas Pharma US Inc | 5 | $77 |
| Otsuka America Pharmaceutical, Inc. | 3 | $50 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $49 |
| E.R. Squibb & Sons, L.L.C. | 3 | $49 |
| Radius Health, Inc. | 2 | $28 |
Products named: VRAYLAR, ELIQUIS, NURTEC ODT, FARXIGA, Wegovy, Veozah, QULIPTA, TRELEGY ELLIPTA.
Industry payments across NE — which companies pay providers there.
